Lv1
48 积分 2025-01-15 加入
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
21天前
已完结
Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology
1个月前
已完结
Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis
1个月前
已完结
Lessons from Animal Models in Sjögren's Syndrome
1个月前
已完结
Sjögren syndrome
1个月前
已完结
Targeting the BAFF and APRIL Pathway in IgA Nephropathy: From Disease Pathogenesis to Clinical Trial Evidence
2个月前
已完结
TargetedmRNA Delivery Using Bispecific Antibody-LipidNanoparticle Complexes
3个月前
已完结
Pharmacokinetics and Immunogenicity Investigation of a Human Anti-Interleukin-17 Monoclonal Antibody in Non-Naïve Cynomolgus Monkeys
3个月前
已完结
The value of non-human primates in the development of monoclonal antibodies
3个月前
已完结